Federico Navarro

Sevilla, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Erratum corrige: "Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study". J.L. Pablos et al.

Erratum corrige: "Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study". J.L. Pablos et al.

Journal: Clinical and experimental rheumatology

Published: May 27, 2020

Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain.

Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain.

Journal: Clinical rheumatology

Published: March 03, 2020

Correction to: Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study.

Correction to: Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study.

Journal: Clinical rheumatology

Published: April 12, 2019

Abatacept retention and clinical outcomes in Austrian patients with rheumatoid arthritis: real-world data from the 2-year ACTION study.

Abatacept retention and clinical outcomes in Austrian patients with rheumatoid arthritis: real-world data from the 2-year ACTION study.

Journal: Wiener medizinische Wochenschrift (1946)

Published: March 27, 2019

Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study.

Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study.

Journal: Clinical rheumatology

Published: October 25, 2018

Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study.

Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study.

Journal: Clinical and experimental rheumatology

Published: March 20, 2018

Diagnostic utility of oxidative damage markers for early rheumatoid arthritis in non-smokers and negative anti-CCP patients.

Diagnostic utility of oxidative damage markers for early rheumatoid arthritis in non-smokers and negative anti-CCP patients.

Journal: Anales del sistema sanitario de Navarra

Published: May 30, 2014

Lack of replication of interactions between polymorphisms in rheumatoid arthritis susceptibility: case-control study.

Lack of replication of interactions between polymorphisms in rheumatoid arthritis susceptibility: case-control study.

Journal: Arthritis research & therapy

Published: March 24, 2014

Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysis.

Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysis.

Journal: Arthritis research & therapy

Published: October 09, 2013

Quality-of-care standards for early arthritis clinics.

Quality-of-care standards for early arthritis clinics.

Journal: Rheumatology international

Published: January 21, 2013

Rheumatoid factor does not predict response to TNF antagonists in rheumatoid arthritis: three centers experience.

Rheumatoid factor does not predict response to TNF antagonists in rheumatoid arthritis: three centers experience.

Journal: Joint bone spine

Published: September 17, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026